|
US2012157402A1
|
|
Methods for treating brain tumors
|
|
US2012157400A1
|
|
Methods for treating Kaposi sarcoma
|
|
US2012202801A1
|
|
Methods for treating breast cancer
|
|
WO2010002985A1
|
|
Bmi-1 protein expression modulators
|
|
US2010158858A1
|
|
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
|
US2008064683A1
|
|
Inhibition of VEGF translation
|
|
US2007254878A1
|
|
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
|
US9068234B2
|
|
Methods and agents for screening for compounds capable of modulating gene expression
|
|
US2004214223A1
|
|
Methods and agents for screening for compounds capable of modulating VEGF expression
|
